• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Genetics Market
    Genetics News
    Genetics Stocks
    • Genetics Market
    • Genetics News
    • Genetics Stocks

    Thermo Fisher Scientific Expands Global Footprint to Support Cell and Gene Therapy Clinical Trials in Japan

    Chelsea Pratt
    Oct. 03, 2016 06:22AM PST
    Genetics Investing

    To help meet increasing demand for cell and gene therapy clinical trial support around the globe, Thermo Fisher Scientific, the world leader in serving science, today announced the expansion of its Fisher BioServices cryogenic service capabilities in Japan.

    To help meet increasing demand for cell and gene therapy clinical trial support around the globe, Thermo Fisher Scientific, the world leader in serving science, today announced the expansion of its Fisher BioServices cryogenic service capabilities in Japan.
    This expansion enables its customers to seamlessly conduct clinical trials across multiple
    geographies and provides patients around the world with access to life
    changing therapies. As a leading service provider to the cell and gene
    therapy community, Fisher BioServices is uniquely positioned with the
    experience, resources, and global expertise to support its customers on
    their path towards commercialization.
    The facility in Tokyo was expanded to include cryogenic storage and
    logistics by utilizing a combination of proven components and validated
    procedures developed with years of experience in the cell and gene
    therapy business. The new modules within this facility allow Fisher
    BioServices to configure and replicate each site to meet the specific
    requirements of individual clinical trials with minimal variation,
    regardless of volume or geographic location. The facility is also
    supported by a global comprehensive and integrated Quality System based
    on regulatory requirements, industry best practices and trained
    personnel.
    “Japan is an increasingly important market for cell and gene therapy
    companies conducting clinical trials,” said Dennis Barger, Fisher
    BioServices vice president and general manager. “The addition of
    cryogenic services to this facility in Japan, combined with our existing
    capabilities in Europe and the US, enables us to seamlessly support our
    customers’ global trials as they develop and commercialize their
    therapies.”
    About Thermo Fisher Scientific
    Thermo Fisher Scientific Inc.
    (NYSE: TMO) is the world leader in serving science, with revenues of $17
    billion and more than 50,000 employees in 50 countries. Our mission is
    to enable our customers to make the world healthier, cleaner and safer.
    We help our customers accelerate life sciences research, solve complex
    analytical challenges, improve patient diagnostics and increase
    laboratory productivity. Through our premier brands – Thermo Scientific,
    Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services
    – we offer an unmatched combination of innovative technologies,
    purchasing convenience and comprehensive support. For more information,
    please visit www.thermofisher.com.

    clinical trialseuropecell therapy
    The Conversation (0)

    Go Deeper

    AI Powered
    Microscopic view of stem cells.

    Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×